Evaluation of a novel autoinjector for subcutaneous self-administration of belimumab in systemic lupus erythematosus

Objective: To study self-administration and pharmacokinetics (PK) of subcutaneous (SC) belimumab in patients with systemic lupus erythematosus (SLE). Methods: Patients previously treated with belimumab self-administered belimumab 200 mg SC weekly for 8 weeks using an autoinjector. The primary endpoi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Clin Pharmacol Ther
Hlavní autoři: Sheikh, Saira Z., Hammer, Anne E., Fox, Norma Lynn, Groark, James, Struemper, Herbert, Roth, David, Gordon, David
Médium: Artigo
Jazyk:Inglês
Vydáno: Dustri-Verlag Dr. Karl Feistle 2016
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5100660/
https://ncbi.nlm.nih.gov/pubmed/27668697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5414/CP202623
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky